Document Detail

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.
MedLine Citation:
PMID:  8381056     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Sumatriptan (GR43175) is a selective 5-hydroxytryptamine (5HT1) receptor agonist effective in the acute treatment of migraine. Recent in vitro experiments suggest that it has vasoactive properties in vascular beds distinct from the cerebral circulation. The object of this study was to assess the vasoactive effects of the standard 6-mg subcutaneous dose of sumatriptan used in migraine on the systemic and pulmonary circulations and the coronary artery vasculature. METHODS AND RESULTS: Ten patients undergoing diagnostic coronary arteriography were studied with digital subtraction angiography and invasive hemodynamic monitoring. After subcutaneous injection of sumatriptan, there was no significant change in heart rate or ECG morphology. There was a significant rise in the systemic (20%, p < 0.05 by ANOVA) and pulmonary artery (40%, p < 0.05 by ANOVA) pressures. There was no change in cardiac output, but there was a significant increase in total systemic (27%, p < 0.05) and total pulmonary vascular resistance (40%, p < 0.05). Sumatriptan caused a significant reduction (p < 0.001 by ANOVA) in mean absolute coronary artery diameter, from 4.36 +/- 1.60 mm at baseline to 3.67 +/- 1.49 mm (16%) at 10 minutes and to 3.63 +/- 1.49 mm (17%) at 30 minutes after injection. There were no clinical sequelae. CONCLUSIONS: Sumatriptan, a 5HT1 receptor agonist administered by the subcutaneous route, causes a vasopressor response in the systemic and pulmonary arterial circulations and coronary artery vasoconstriction.
P D MacIntyre; B Bhargava; K J Hogg; J D Gemmill; W S Hillis
Related Documents :
16963536 - Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension.
3889746 - Short-term responses in neonatal lambs after infusion of group b streptococcal extract.
20583396 - Sildenafil and beraprost combination therapy in patients with pulmonary hypertension un...
23876886 - Kruppel-like factor 2 might mediate the rapamycin-induced arterial thrombosis in vivo: ...
7865866 - Endothelium-denuded pulmonary resistance arteries from the fetal lamb: preparation and ...
12883516 - Methodology for a rapid protocol to rule out pulmonary embolism in the emergency depart...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Circulation     Volume:  87     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-03-03     Completed Date:  1993-03-03     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  401-5     Citation Subset:  AIM; IM    
Department of Medicine and Therapeutics, University of Glasgow, Scotland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Circulation / drug effects*
Coronary Circulation / drug effects*
Coronary Vessels / drug effects
Hemodynamics / drug effects
Indoles / blood,  pharmacology*
Injections, Subcutaneous
Middle Aged
Pulmonary Circulation / drug effects*
Reproducibility of Results
Sulfonamides / blood,  pharmacology*
Vasoconstrictor Agents / pharmacology
Reg. No./Substance:
0/Indoles; 0/Sulfonamides; 0/Vasoconstrictor Agents; 103628-46-2/Sumatriptan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in h...
Next Document:  Uncoupling of human cardiac beta-adrenoceptors during cardiopulmonary bypass with cardioplegic cardi...